Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
China flag China · Delayed Price · Currency is CNY
4.800
-0.100 (-2.04%)
At close: Feb 13, 2026

SHA:603718 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
246.33271.02231.35294.12346.15258.32
Other Revenue
0.020.029.375.871.140.8
246.35271.04240.72299.99347.29259.13
Revenue Growth (YoY)
11.70%12.59%-19.76%-13.62%34.02%-6.79%
Cost of Revenue
60.34110.39120.3124.61158.4140.2
Gross Profit
186.01160.65120.42175.38188.89118.93
Selling, General & Admin
69.37111.9599.77126.85129.9118.23
Research & Development
24.7524.4524.9729.9428.6429.53
Other Operating Expenses
3.222.171.43.333.52.27
Operating Expenses
99.86142.12126.92159.69166.99156.29
Operating Income
86.1518.53-6.515.6921.9-37.36
Interest Expense
-2.59-5.49-5.39-10.31-12.38-17.69
Interest & Investment Income
158.61160.6175.8216.4327.7923.61
Currency Exchange Gain (Loss)
10.310.3-0.01-0.060.281.3
Other Non Operating Income (Expenses)
-35.94-0.4-0.291.38-1.61-0.14
EBT Excluding Unusual Items
216.53183.5563.6323.1435.99-30.28
Impairment of Goodwill
-1.19-1.19----
Gain (Loss) on Sale of Investments
-9.19-12.76-16.52-2.978.281.62
Gain (Loss) on Sale of Assets
-0.48-0.710.55-0.367.41-2.78
Other Unusual Items
39.1139.228.36111.415.468.09
Pretax Income
244.78208.1256.02131.2257.14-23.34
Income Tax Expense
40.9326.486.0120.5311.478.81
Earnings From Continuing Operations
203.85181.6450.01110.6945.67-32.15
Minority Interest in Earnings
-32.51-10.4612.8610.928.1941.08
Net Income
171.34171.1862.87121.6153.868.93
Net Income to Common
171.34171.1862.87121.6153.868.93
Net Income Growth
1953.15%172.28%-48.30%125.80%503.33%-26.54%
Shares Outstanding (Basic)
622634629640673893
Shares Outstanding (Diluted)
646658629640673893
Shares Change (YoY)
-3.04%4.72%-1.77%-4.93%-24.58%46.92%
EPS (Basic)
0.280.270.100.190.080.01
EPS (Diluted)
0.270.260.100.190.080.01
EPS Growth
2017.74%160.00%-47.37%137.50%700.00%-50.00%
Free Cash Flow
53.7538.08-16.18273.065.85133.56
Free Cash Flow Per Share
0.080.06-0.030.430.010.15
Dividend Per Share
0.0780.0780.0290.057-0.004
Dividend Growth
173.17%173.17%-49.38%---30.00%
Gross Margin
75.50%59.27%50.02%58.46%54.39%45.90%
Operating Margin
34.97%6.84%-2.70%5.23%6.30%-14.42%
Profit Margin
69.55%63.16%26.12%40.54%15.51%3.45%
Free Cash Flow Margin
21.82%14.05%-6.72%91.02%1.69%51.54%
EBITDA
120.253.2729.1656.8678.7920.86
EBITDA Margin
48.79%19.65%12.11%18.95%22.69%8.05%
D&A For EBITDA
34.0634.7435.6641.1756.958.22
EBIT
86.1518.53-6.515.6921.9-37.36
EBIT Margin
34.97%6.84%-2.70%5.23%6.30%-14.42%
Effective Tax Rate
16.72%12.72%10.73%15.64%20.08%-
Revenue as Reported
246.35271.04240.72299.99347.29259.13
Advertising Expenses
-3.813.223.673.738.4
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.